EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

The Polycystic Kidney Disease Cyst Transcriptome Defined by Integrating Spatial, Single-Nuclear, and Bulk Transcriptomics

Muhammad Ibrahim Khan, Jielu Hao Robichaud, Humayra Afrin, Fouad T Chebib, Peter C Harris iD, Navin R Gupta iD

Kidney360 · 2026-11 · 7 (11) · 2431-2449

DOI: 10.34067/kid.0000001371 ↗

At a glance

Journal article in Kidney360, published online on 2026-09-28. Written by Muhammad Ibrahim Khan and 5 co-authors. Institution: Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN. 85 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIDDK NIH HHS, NCATS NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Key Points Spatial transcriptomics is able to morphologically and transcriptionally characterize the autosomal dominant polycystic kidney disease cyst transcriptome and interactome. Autosomal dominant polycystic kidney disease cysts:fibroblast interactome suggests migration inhibitory factor and osteopontin signals from cysts and TNF-like weak inducer of apoptosis, tenascin-C, and pleiotrophin signaling into cysts. Yes-associated protein and transcriptional coactivator with PDZ-binding motif, TGF- β /SMAD3, and mTORC2/SGK1 are putatively involved in the cystic transformation of principal cells.

Background

Autosomal dominant polycystic kidney disease (ADPKD) has been transcriptionally profiled at single cellular resolution, yet dissociation eliminated cyst-defining morphology to preclude a retrograde analysis of the cyst transcriptome. Transcriptional profiling of dissected ADPKD cysts has demonstrated size-based transcriptional heterogeneity, impossible to define in prior single cell analysis, but sampling was neither single cell nor comprehensive to limit downstream transcriptional analysis.

Methods

10× Genomics Visium spatial transcriptomics of an ADPKD patient sample morphologically recognizes cysts to spatially characterize their ligand-receptor engagement, the signaling pathways of cystic transformation, and candidate cystic anchor genes that are specific and sensitive for cystic epithelia. Anchor gene validation in single-nuclear RNA sequencing and cyst bulk RNA sequencing enhanced resolution, extended to cysts of variable size, and corroborated across ADPKD samples, before confirmatory confocal microscopy for protein-level localization.

Results

The polycystic kidney disease interactome may be enriched for vascular endothelial growth inhibitor–mediated hypoxia, fibrotic extracellular matrix, and proinflammatory TGF- β , tumor necrosis factor, and interferon- γ signaling. Enhanced ligand-receptor engagement between cysts and fibroblasts suggests osteopontin and macrophage migration inhibitory factor signals emanate from cysts and TNF-like weak inducer of apoptosis (TWEAK), tenascin-C, and pleiotrophin signals into cysts. Cystic principal cells, standardized to noncystic counterparts, implicate Hippo (yes-associated protein and transcriptional coactivator with PDZ-binding motif [YAP/TAZ]), TGF- β /SMAD3, and mammalian target of rapamycin (mTORC2/SGK1) signaling in cystic transformation, while pathway analysis newly implicates nicotinic acetylcholine, cadherin, toll-like, and cholecystokinin receptor signaling. Top differentially expressed genes of cystic principal cells, interrogated for their specificity for cysts and their consistency across individual samples of single-cell and cyst bulk RNA-seq, prioritizes musculin as a cystic anchor gene.

Conclusions

Spatial transcriptomics morphologically and transcriptionally characterizes the polycystic kidney disease transcriptome. Ligand-receptor, pathway, and reactome analyses may provide clinically relevant disease associations that inform mechanistic studies in animal and organoid models. Integrating spatial, single nuclear, and cyst bulk RNA-seq spatially recognizes cysts at single-cell resolution, while accounting for size-based heterogeneity of cysts.

Authors and institutions

  • Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
  • Division of Nephrology and Hypertension, Mayo Clinic, Jacksonville FL.
  • Division of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN.

ORCID profiles: Peter C Harris, Navin R Gupta

Funding

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • Center for Clinical and Translational Science, Mayo Clinic
  • Mayo Clinic

Cite

APA

Khan, M. I., Robichaud, J. H., Afrin, H., Chebib, F. T., Harris, P. C., & Gupta, N. R. (2026). The Polycystic Kidney Disease Cyst Transcriptome Defined by Integrating Spatial, Single-Nuclear, and Bulk Transcriptomics. Kidney360, 7(11), 2431-2449. https://doi.org/10.34067/kid.0000001371

Vancouver

Khan MI, Robichaud JH, Afrin H, Chebib FT, Harris PC, Gupta NR. The Polycystic Kidney Disease Cyst Transcriptome Defined by Integrating Spatial, Single-Nuclear, and Bulk Transcriptomics. Kidney360. 2026;7(11):2431-2449. doi:10.34067/kid.0000001371

BibTeX
@article{Khan2026,
  author = {Khan, Muhammad Ibrahim and Robichaud, Jielu Hao and Afrin, Humayra and Chebib, Fouad T and Harris, Peter C and Gupta, Navin R},
  title = {The Polycystic Kidney Disease Cyst Transcriptome Defined by Integrating Spatial, Single-Nuclear, and Bulk Transcriptomics},
  journal = {Kidney360},
  year = {2026},
  volume = {7},
  number = {11},
  pages = {2431--2449},
  doi = {10.34067/kid.0000001371}
}
Start for free →